Burow M. Kristina's Insider Trades & SAST Disclosures
Burow M. Kristina's most recent trade in Neumora Therapeutics Inc. was a trade of 46,455 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 13, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Burow M. Kristina.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Neumora Therapeutics Inc. | Kristina M. Burow | Director, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 0.00 per share. | 13 Feb 2025 | 46,455 | 0 | - | - | Stock Option (Right to Buy) | |
| Neumora Therapeutics Inc. | Kristina M. Burow | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 46,455 | 46,455 | - | - | Stock Option (Right to Buy) | |
| Neumora Therapeutics Inc. | Kristina M. Burow | Director, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 0.00 per share. | 13 Feb 2025 | 28,571 | 0 | - | - | Stock Option (Right to Buy) | |
| Neumora Therapeutics Inc. | Kristina M. Burow | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 28,571 | 28,571 | - | - | Stock Option (Right to Buy) | |
| Metsera Inc. | Kristina M. Burow | Director, Ten Percent Owner | 03 Feb 2025 | 19,933,333 | 0 | - | - | Series Seed Preferred Stock | ||
| Metsera Inc. | Kristina M. Burow | Director, Ten Percent Owner | 03 Feb 2025 | 16,006,949 | 17,070,904 | - | - | Common Stock | ||
| Metsera Inc. | Kristina M. Burow | Director, Ten Percent Owner | 03 Feb 2025 | 15,000,000 | 0 | - | - | Series A Convertible Preferred Stock | ||
| Metsera Inc. | Kristina M. Burow | Director, Ten Percent Owner | 03 Feb 2025 | 15,000,000 | 0 | - | - | Series A Convertible Preferred Stock | ||
| Metsera Inc. | Kristina M. Burow | Director, Ten Percent Owner | 03 Feb 2025 | 7,523,682 | 7,523,682 | - | - | Common Stock | ||
| Metsera Inc. | Kristina M. Burow | Director, Ten Percent Owner | 03 Feb 2025 | 2,678,571 | 0 | - | - | Series B Convertible Preferred Stock | ||
| Metsera Inc. | Kristina M. Burow | Director, Ten Percent Owner | 03 Feb 2025 | 2,678,571 | 0 | - | - | Series B Convertible Preferred Stock | ||
| Metsera Inc. | Kristina M. Burow | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 18.00 per share. | 03 Feb 2025 | 1,432,224 | 18,503,128 | - | 18 | 25,780,032 | Common Stock |
| Metsera Inc. | Kristina M. Burow | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 18.00 per share. | 03 Feb 2025 | 789,998 | 8,313,680 | - | 18 | 14,219,964 | Common Stock |
| Scholar Rock Holding Corp | Kristina M. Burow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2024 | 18,000 | 18,000 | - | - | Stock Option (Right to Buy) | |
| Scholar Rock Holding Corp | Kristina M. Burow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2024 | 13,500 | 18,839 (0%) | 0% | 0 | Common Stock | |
| Neumora Therapeutics Inc. | Kristina M. Burow | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 28,571 | 28,571 | - | - | Stock Option (Right to Buy) | |
| Neumora Therapeutics Inc. | Kristina M. Burow | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 20,100 | 47,717 | - | 0 | Common Stock | |
| Boundless Bio Inc. | Kristina M. Burow | Director, Ten Percent Owner | 02 Apr 2024 | 1,048,433 | 1,048,433 | - | - | Common Stock | ||
| Boundless Bio Inc. | Kristina M. Burow | Director, Ten Percent Owner | 02 Apr 2024 | 787,545 | 828,570 | - | - | Common Stock | ||
| Boundless Bio Inc. | Kristina M. Burow | Director, Ten Percent Owner | 02 Apr 2024 | 589,743 | 617,092 | - | - | Common Stock | ||
| Boundless Bio Inc. | Kristina M. Burow | Director, Ten Percent Owner | 02 Apr 2024 | 586,080 | 0 | - | - | Series A Convertible Preferred Stock | ||
| Boundless Bio Inc. | Kristina M. Burow | Director, Ten Percent Owner | 02 Apr 2024 | 454,212 | 0 | - | - | Series A Convertible Preferred Stock | ||
| Boundless Bio Inc. | Kristina M. Burow | Director, Ten Percent Owner | 02 Apr 2024 | 424,908 | 0 | - | - | Series A Convertible Preferred Stock | ||
| Boundless Bio Inc. | Kristina M. Burow | Director, Ten Percent Owner | 02 Apr 2024 | 366,301 | 0 | - | - | Series C Convertible Preferred Stock | ||
| Boundless Bio Inc. | Kristina M. Burow | Director, Ten Percent Owner | 02 Apr 2024 | 227,920 | 0 | - | - | Series B Convertible Preferred Stock | ||
| Boundless Bio Inc. | Kristina M. Burow | Director, Ten Percent Owner | 02 Apr 2024 | 201,465 | 0 | - | - | Series C Convertible Preferred Stock | ||
| Boundless Bio Inc. | Kristina M. Burow | Director, Ten Percent Owner | 02 Apr 2024 | 164,835 | 0 | - | - | Series C Convertible Preferred Stock | ||
| Boundless Bio Inc. | Kristina M. Burow | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 16.00 per share. | 02 Apr 2024 | 133,333 | 1,181,766 | - | 16 | 2,133,328 | Common Stock |
| Boundless Bio Inc. | Kristina M. Burow | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 16.00 per share. | 02 Apr 2024 | 66,667 | 683,759 | - | 16 | 1,066,672 | Common Stock |
| Boundless Bio Inc. | Kristina M. Burow | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2024 | 26,438 | 26,438 | - | - | Stock Option | |
| Scholar Rock Holding Corp | M. Kristina Burow | Director | Other type of transaction at price $ 0.00 per share. | 21 Dec 2023 | 291,906 | 2,345,711 (7%) | 0% | 0 | Common Stock | |
| Scholar Rock Holding Corp | Burow M. Kristina | Director | Other type of transaction at price $ 0.00 per share. | 21 Dec 2023 | 5,339 | 5,339 (0%) | 0% | 0 | Common Stock | |
| Scholar Rock Holding Corp | Kristina M. Burow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2023 | 36,000 | 36,000 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Kristina M. Burow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 35,000 | 35,000 | - | - | Stock Option (Right to Buy) | |
| Beam Therapeutics Inc | Kristina M. Burow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 16,532 | 16,532 | - | - | Stock Option (Right to Buy) | |
| Beam Therapeutics Inc | Kristina M. Burow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2022 | 10,391 | 10,391 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Kristina M. Burow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Scholar Rock Holding Corp | Kristina M. Burow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2022 | 28,000 | 28,000 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges